Nyxoah (BR:NYXH) — Market Cap & Net Worth
Market Cap & Net Worth: Nyxoah (NYXH)
Nyxoah (BR:NYXH) has a market capitalization of $68.91 Million (€58.95 Million) as of September 17, 2026. Listed on the BR stock exchange, this Belgium-based company holds position #20753 globally and #90 in its home market, demonstrating a -3.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nyxoah's stock price €1.37 by its total outstanding shares 43026460 (43.03 Million). Also see NYXH total asset value for a full breakdown of the balance sheet.
Nyxoah Market Cap History: 2020 to 2026
Nyxoah's market capitalization history from 2020 to 2026. Data shows change from $794.78 Million to $68.91 Million (-35.79% CAGR). Also see Nyxoah cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Nyxoah is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
BEL Small
BELS
|
$5.85 Billion | 1.18% | #19 of 20 |
|
BEL All Share
BSPT
|
$835.12 Billion | 0.01% | #92 of 108 |
Weight: Nyxoah's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nyxoah Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nyxoah's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check NYXH stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
91.90x
Nyxoah's market cap is 91.90 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $794.78 Million | $69.00K | -$12.24 Million | 11518.53x | N/A |
| 2021 | $935.63 Million | $852.00K | -$27.62 Million | 1098.15x | N/A |
| 2022 | $258.55 Million | $3.08 Million | -$31.23 Million | 83.84x | N/A |
| 2023 | $214.29 Million | $4.35 Million | -$43.21 Million | 49.28x | N/A |
| 2024 | $415.50 Million | $4.52 Million | -$59.24 Million | 91.90x | N/A |
Competitor Companies of NYXH by Market Capitalization
Companies near Nyxoah in the global market cap rankings as of September 17, 2026. Review Nyxoah (NYXH) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Nyxoah by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #176 globally with a market cap of $135.13 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #354 globally with a market cap of $78.17 Billion USD ( €66.86 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #422 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #543 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #176 | Intuitive Surgical Inc | NASDAQ:ISRG | $135.13 Billion | $377.16 |
| #354 | EssilorLuxottica S. A. | PA:EL | $78.17 Billion | €144.40 |
| #422 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €71.50 |
| #543 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Nyxoah Historical Marketcap From 2020 to 2026
Between 2020 and today, Nyxoah's market cap moved from $794.78 Million to $ 68.91 Million, with a yearly change of -35.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €68.91 Million | -66.46% |
| 2025 | €205.49 Million | -50.54% |
| 2024 | €415.50 Million | +93.90% |
| 2023 | €214.29 Million | -17.12% |
| 2022 | €258.55 Million | -72.37% |
| 2021 | €935.63 Million | +17.72% |
| 2020 | €794.78 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Nyxoah was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $68.91 Million USD |
| MoneyControl | $68.91 Million USD |
| MarketWatch | $68.91 Million USD |
| marketcap.company | $68.91 Million USD |
| Reuters | $68.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nyxoah
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgi… Read more